Skip to content

Correlations Between Symptoms of Anxiety And/or Depression with Dysphagia Severity Level

Correlations Between Symptoms of Anxiety And/or Depression with Dysphagia Severity Level

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06587555
Enrollment
30
Registered
2024-09-19
Start date
2024-10-01
Completion date
2025-03-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Dysphagia

Keywords

Dysphagia Severity Level, Anxiety, Depression, Dyspahgia, HADS

Brief summary

The goal of this observational study is to know any CORRELATIONS BETWEEN SYMPTOMS OF ANXIETY AND / OR DEPRESSION WITH DYSPHAGIA SEVERITY LEVEL in is all of the new or ongoing patients with dysphagia in the Neurorehabilitation Department at Hasan Sadikin General Hospital Bandung and who meet the inclusion and exclusion criteria. The main questions it aims to answer are: Hypothesis 1 H0 : There is no correlation between increased severity of dysphagia and higher levels of anxiety symptoms H1 : There is a correlation between increased severity of dysphagia and higher levels of anxiety Hypothesis 2 H0 : There is no correlation between increased severity level of dysphagia and higher level of depression symptoms H1 : There is a correlation between increased severity of dysphagia and higher levels of depression Hypothesis 3 H0 : There is no correlation between increased severity level of anxiety and dysphagia and higher level of depression symptoms H1 : There is a correlation between increased severity of anxiety and dysphagia and higher levels of depression

Detailed description

This study is an analytical observational study with a cross-sectional design, then correlation analysis was carried out, to analyse the correlation between Severity level of dysphagia with anxiety and / or depression. This Study performed at Hasan Sadikin Hospital between August 2024 - March 2025 Study Subject : The target population for this study is all of the new or ongoing patients with dysphagia in the Neurorehabilitation Department at Hasan Sadikin General Hospital Bandung and who meet the inclusion and exclusion criteria. Inclusion criteria : * Participants aged 18 years and above. * Individuals diagnosed with dysphagia by a qualified healthcare professional * Participants with documented anxiety and/or depression symptoms were assessed using standardized psychological assessments * Willing to participate Exclusion criteria : Participants who have MOCA INA \< 18 Participants with severe malnutrition, showed by BMI WHO Asia Pacific \< 18.5 Participants with unstable hemodynamics, GCS \< 15 Participants who had a history of diagnosed anxiety and / or depression Participants who had a history of using an antipsychotic drug Sample Size Determination : The sample size in this study was determined using correlation analysis, to see the correlation between variables, with a minimum number of samples of 30 research subjects obtained. Confounding Factors : 1. Underlying disease 2. Age 3. Duration of Rehabilitation Therapy 4. Type of Rehabilitation Theraphy

Interventions

None listed

Sponsors

Universitas Padjadjaran
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participants aged 18 years and above. 2. Individuals diagnosed with dysphagia by a qualified healthcare professional 3. Participants with documented anxiety and/or depression symptoms were assessed using standardized psychological assessments 4. Willing to participate

Exclusion criteria

1. Participants who have MOCA INA \< 18 2. Participants with severe malnutrition, showed by BMI WHO Asia Pacific \< 18.5 3. Participants with unstable hemodynamics, GCS \< 15 4. Participants who had a history of diagnosed anxiety and / or depression 5. Participants who had a history of using an antipsychotic drug

Design outcomes

Primary

MeasureTime frameDescription
Anxiety and / or Depression Symptoms Measure using HADS questionarySeptember 2024 - January 2025Hospital Anxiety and Depression Questionnaire (HADS) are ranging from 0-7 points meaning no depression/ anxiety cases (ie, non- cases), 8-10 points representing borderline or doubtful cases, and ≥11 points suggesting anxiety or depressive cases

Countries

Indonesia

Contacts

Primary ContactVitriana Biben
vitriana@unpad.ac.id+628156262733
Backup ContactRegina Emmanuela Gusti Pratiwi
reginaemmanuela@gmail.com+6282119757188

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026